The development of new radiochemistry is central to our research strategy.
Our laboratories have developed a large portfolio of radiochemical transformations (18F and 123I) to meet the demands of imaging scientists. Our technologies enable access to structurally and functionally diverse radiolabelled compounds-from small molecule radiotracers to labelled biomolecules, such as peptides and proteins.
